Paul Lin

8PUBLICATIONS
89CO-AUTHORS
Transplantation immunologyPredictive and prognostic markersRegenerative medicine (incl. stem cells)Gene and molecular therapyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 05, 2026
D-VRD induction and autologous transplant in patients ≥70 years.

|Oct 27, 2025
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.

Paul Lin, Sunil Acharya, Francia Reyes-Silva

|Nov 01, 2024
Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.

Oren Pasvolsky, Curtis Marcoux, Denái R Milton

|Sep 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Bijender Kumar, Anand Singh, Rafet Basar

|Jun 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

Sunil Acharya, Rafet Basar, May Daher

|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.

Oren Pasvolsky, Zhongya Wang, Denái R Milton

Pageof 2

Frequent Collaborators

5 joint publications

Katayoun Rezvani

5 joint publications

May Daher

4 joint publications

Hind Rafei

4 joint publications

Vakul Mohanty